HBK Investments’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-36,000
Closed -$6.88M 619
2019
Q4
$6.88M Hold
36,000
0.07% 190
2019
Q3
$6.06M Hold
36,000
0.08% 213
2019
Q2
$6.03M Buy
+36,000
New +$4.98M 0.05% 189
2018
Q4
Sell
-4,700
Closed -$895K 1506
2018
Q3
$895K Buy
+4,700
New +$863K 0.01% 765
2016
Q2
Sell
-71,400
Closed -$19.1M 1143
2016
Q1
$19.1M Buy
+71,400
New +$20.4M 0.19% 80

Other funds holding AGN

HBK Investments's AGN Position: Q2 2019 in Review

HBK Investments sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 2,600 shares — an estimated $360K sold.

HBK Investments first reported a position in AGN in Q3 2013 and held it in 8 quarters. The position peaked at $19.4M in Q4 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • HBK Investments reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 2,600 Allergan plc shares in Q2 2019, an estimated $360K.
  • HBK Investments first reported a position in Allergan plc in Q3 2013 and held it in 8 quarters.
  • HBK Investments's Allergan plc position peaked at $19.4M in Q4 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.